Comparison of Valproic Acid and Lithium in Mania
J Clin Psychiatry 1997;58:273 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: In their discussion, Frye et al. failed to account for
several crucial effects that undermine the results of their study
that compared valproic acid and lithium.
First, because every patient taking lithium was also taking a
neuroleptic and a benzodiazepine at hospital discharge, the
study population was lithium-resistant. Lithium resistance is also suggested by the long duration of illness prior to hospitalization.
Simply, lithium does not work in lithium-resistant patients,
and subject selection biased the results against lithium.